Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Zimmer Biomet (ZBH) Recovery Rate Slows Down Amid Pandemic

By Zacks Investment ResearchStock MarketsAug 09, 2021 11:10PM ET
Zimmer Biomet (ZBH) Recovery Rate Slows Down Amid Pandemic
By Zacks Investment Research   |  Aug 09, 2021 11:10PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items

Zimmer Biomet Holdings (NYSE:ZBH), Inc. ZBH continues to gain market share in the Asia Pacific, Europe, the Middle East and Africa (EMEA) regions. However, slower recovery amid the emergence of a new strain of coronavirus remains a major concern. The company currently has a Zacks Rank #4 (Sell).

In the past year, Zimmer Biomet has underperformed its industry. The stock has gained 7.7% compared with 11.7% growth of the industry.

EMEA sales grew 80.5% year over year but were down 7.3% from the pre-pandemic sales level of 2019 with continued pressure related to the pandemic being a major factor. The company is also concerned about the fact that the Asia Pacific business, which was largely stable in recent times, got impacted late in the second quarter by channel inventory contraction in knee and hip categories within China.

In addition, the company saw a resurgence and increase in COVID-19 in a number of markets, including Japan. While Zimmer Biomet is seeing sequential improvement in the recovery of procedural volumes in large joints, getting back to normalized market growth is taking longer than expected.

The company’s leveraged capital structure is an added concern. In the reported quarter, total debt was much higher than the corresponding cash and cash equivalent level, indicating a tough solvency position. The company’s near-termpayable debt too was higher than the present level of cash in hand. This is a matter of concern for investors as during the period of global economic uncertainties, its cash and cash equivalent was not sufficient even for short-term debt repayment.

Further, pricing continues to remain a major headwind for Zimmer Biomet.

On a positive note, Zimmer Biomet ended the second quarter of 2021 with better-than-expected revenues and earnings. Year-over-year earnings and constant currency revenue growth were extremely robust. Sales improved across all its operating segments and geographies as recovery from the pandemic continued through the months of the second quarter.

Despite some ongoing COVID-19 pressure, the company expects continued improvement in procedure volume recovery through the second half of 2021. Strong demand and favorable customer feedback continued for Avenir Complete hip. New products and better commercial execution drove growth in the quarter with strong contributions from implants and digital solutions within the dental business.

When compared to the second quarter of 2019, net sales were flat at CER. Overall, consolidated and regional results were slightly better than expectations in the Americas and Asia Pacific. There was sequential improvement in EMEA in the reported quarter. Strong margin expansion was another upside.

Moreover, Zimmer Biomet’s spin-off decision of the non-core dental and spine business is expected to prove strategic.

Key Picks

A few better-ranked stocks from the broader medical space are Envista Holdings (NYSE:NVST) Corporation NVST, Hill-Rom (NYSE:HRC) Holdings, Inc. HRC and Henry Schein (NASDAQ:HSIC), Inc. HSIC, each carrying a Zacks Rank #2 (Buy). You can see the complete list of Zacks #1 Rank (Strong Buy) stocks here.

Envista has a projected long-term earnings growth rate of 27%.

Hill-Rom Holdings has a projected long-term earnings growth rate of 8%.

Henry Schein has an estimated long-term earnings growth rate of 14%.

Zacks' Top Picks to Cash in on Artificial Intelligence

In 2021, this world-changing technology is projected to generate $327.5 billion in revenue. Now Shark Tank star and billionaire investor Mark Cuban says AI will create "the world's first trillionaires." Zacks' urgent special report reveals 3 AI picks investors need to know about today.

See 3 Artificial Intelligence Stocks With Extreme Upside Potential>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Henry Schein, Inc. (HSIC): Free Stock Analysis Report

HillRom Holdings, Inc. (HRC): Free Stock Analysis Report

Zimmer Biomet Holdings, Inc. (ZBH): Free Stock Analysis Report

Envista Holdings Corporation (NVST): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research
Zimmer Biomet (ZBH) Recovery Rate Slows Down Amid Pandemic

Related Articles

Zimmer Biomet (ZBH) Recovery Rate Slows Down Amid Pandemic

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email